Medigen Biotechnology Corp - Company Profile

Powered by

All the data and insights you need on Medigen Biotechnology Corp in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date Medigen Biotechnology Corp Strategy Report

  • Understand Medigen Biotechnology Corp position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Medigen Biotechnology Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Medigen Biotechnology Corp (MBC) is a pharmaceutical company that carries out the research and development of biopharmaceuticals for the treatment of liver diseases and cancers. It focuses on developing new therapeutics, principally in the area of cancer and liver diseases. The company’s product portfolio includes monoclonal antibodies; vaccines; molecular diagnostics and generic drugs. MBC also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) manufacturing services in various dosage forms including orals, externals, ophthalmic and hormones; nutrition supplements; cosmeceutical products. The company’s subsidiaries include Medigen Vaccine Biologics; TBG Biotechnology Corp; and Winston Medical Supply Co Ltd. MBC is headquartered in Taipei city, Taiwan.

 Gain a 360-degree view of Medigen Biotechnology Corp and make more informed decisions for your business Gain a 360-degree view of Medigen Biotechnology Corp and make more informed decisions for your business Find out more
Headquarters Taiwan
Address 14f, Bldg F, No. 3, Yuancyu St., Nangang District, Taipei, 115
Website www.medigen.com.tw/en/home
Telephone 886 2 26535200
No of Employees 67
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 3176 (TPO)
Revenue (2022) $35.5M -73.1% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ -1184.6% (2022 vs 2021)
Market Cap* $170.8M
Net Profit Margin (2022) XYZ -4,676.9% (2022 vs 2021)
* As of and is in US$
View Medigen Biotechnology Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

Medigen Biotechnology Corp premium industry data and analytics

50+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Medigen Biotechnology Corp’s relevant decision makers and contact details.

30+

Clinical Trials

Determine Medigen Biotechnology Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

20+

Catalyst Calendar

Proactively evaluate Medigen Biotechnology Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

11+

Pipeline Drugs

Identify which of Medigen Biotechnology Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Medigen Biotechnology Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services
Molecular Diagnostics Drug Development Services
Generic Drugs Original Design Manufacturing
Medical Aesthetic Products Original Equipment Manufacturing
XYZ
XYZ
XYZ
Understand Medigen Biotechnology Corp portfolio and identify potential areas for collaboration Understand Medigen Biotechnology Corp portfolio and identify potential areas for collaboration Find out more
Image for loader

Competitor Comparison

Key Parameters Medigen Biotechnology Corp PhytoHealth Corp NeoCore Technology Co Ltd Lumosa Therapeutics Co Ltd Development Center for Biotechnology
Headquarters Taiwan Taiwan Taiwan Taiwan Taiwan
City Taipei Taipei Tainan Taipei Taipei
State/Province - - - - Taipei
No. of Employees 67 84 37 47 400
Entity Type Public Public Public Public Institution
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Stanley Chang, Ph.D., M.D. Chairman; Chief Executive Officer Executive Board - -
Alarng Chang General Manager Senior Management - -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Medigen Biotechnology Corp key executives to enhance your sales strategy Gain insight into Medigen Biotechnology Corp key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer